drugset / Trial / NCT01085279

Fractional Laser as Treatment Option for Various Pigment Disorders (Fractional-3)

NCT01085279

Phase 2 Completed 29 enrolled Netherlands Institute for Pigment Disorders
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine whether the use of non-ablative fractional laser is safe and effective in the treatment of melasma.

Timeline

Start
2009-03
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydroquinone Small molecule 5 % Topical
Comparator Tretinoin Small molecule 0.05 % Topical
Comparator Triamcinolone Acetonide Other / unclassified 0.1 % Topical